The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Research Report 2025
Synopsis
Highlights
The global Group ACYW135 Meningococcal Polysaccharide Vaccine market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Group ACYW135 Meningococcal Polysaccharide Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Group ACYW135 Meningococcal Polysaccharide Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine include Sanofi-Pasteur, Walvax Biotechnology, Chengdu Kanghua Biological Products Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd, Zhejiang Tianyuan Biopharmaceutical Co., Ltd, Beijing Institute of Biological Products Co., Ltd, CanSino Biologics AG, Yuxi Watson Biotechnology Co., Ltd and Hualan Biovaccine Co., Ltd, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Group ACYW135 Meningococcal Polysaccharide Vaccine in Hospital is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Class I Vaccines, which accounted for % of the global market of Group ACYW135 Meningococcal Polysaccharide Vaccine in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Group ACYW135 Meningococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Group ACYW135 Meningococcal Polysaccharide Vaccine.
The Group ACYW135 Meningococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Group ACYW135 Meningococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Group ACYW135 Meningococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Sanofi-Pasteur
Walvax Biotechnology
Chengdu Kanghua Biological Products Co., Ltd
Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
Zhejiang Tianyuan Biopharmaceutical Co., Ltd
Beijing Institute of Biological Products Co., Ltd
CanSino Biologics AG
Yuxi Watson Biotechnology Co., Ltd
Hualan Biovaccine Co., Ltd
Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
Product Type Insights
Global markets are presented by Group ACYW135 Meningococcal Polysaccharide Vaccine type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Group ACYW135 Meningococcal Polysaccharide Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Group ACYW135 Meningococcal Polysaccharide Vaccine segment by Type
Class I Vaccines
Class II Vaccines
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Group ACYW135 Meningococcal Polysaccharide Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Group ACYW135 Meningococcal Polysaccharide Vaccine market.
Group ACYW135 Meningococcal Polysaccharide Vaccine segment by Application
Hospital
Clinic
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Group ACYW135 Meningococcal Polysaccharide Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Group ACYW135 Meningococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Group ACYW135 Meningococcal Polysaccharide Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Group ACYW135 Meningococcal Polysaccharide Vaccine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Group ACYW135 Meningococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Highlights
The global Group ACYW135 Meningococcal Polysaccharide Vaccine market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Group ACYW135 Meningococcal Polysaccharide Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Group ACYW135 Meningococcal Polysaccharide Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine include Sanofi-Pasteur, Walvax Biotechnology, Chengdu Kanghua Biological Products Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd, Zhejiang Tianyuan Biopharmaceutical Co., Ltd, Beijing Institute of Biological Products Co., Ltd, CanSino Biologics AG, Yuxi Watson Biotechnology Co., Ltd and Hualan Biovaccine Co., Ltd, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Group ACYW135 Meningococcal Polysaccharide Vaccine in Hospital is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Class I Vaccines, which accounted for % of the global market of Group ACYW135 Meningococcal Polysaccharide Vaccine in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Group ACYW135 Meningococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Group ACYW135 Meningococcal Polysaccharide Vaccine.
The Group ACYW135 Meningococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Group ACYW135 Meningococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Group ACYW135 Meningococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Sanofi-Pasteur
Walvax Biotechnology
Chengdu Kanghua Biological Products Co., Ltd
Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
Zhejiang Tianyuan Biopharmaceutical Co., Ltd
Beijing Institute of Biological Products Co., Ltd
CanSino Biologics AG
Yuxi Watson Biotechnology Co., Ltd
Hualan Biovaccine Co., Ltd
Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
Product Type Insights
Global markets are presented by Group ACYW135 Meningococcal Polysaccharide Vaccine type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Group ACYW135 Meningococcal Polysaccharide Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Group ACYW135 Meningococcal Polysaccharide Vaccine segment by Type
Class I Vaccines
Class II Vaccines
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Group ACYW135 Meningococcal Polysaccharide Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Group ACYW135 Meningococcal Polysaccharide Vaccine market.
Group ACYW135 Meningococcal Polysaccharide Vaccine segment by Application
Hospital
Clinic
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Group ACYW135 Meningococcal Polysaccharide Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Group ACYW135 Meningococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Group ACYW135 Meningococcal Polysaccharide Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Group ACYW135 Meningococcal Polysaccharide Vaccine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Group ACYW135 Meningococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Index1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of Group ACYW135 Meningococcal Polysaccharide Vaccine
1.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Type
1.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Class I Vaccines
1.2.3 Class II Vaccines
1.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Application
1.3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue 2017-2028
1.4.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales 2017-2028
1.4.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.5.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Group ACYW135 Meningococcal Polysaccharide Vaccine Players Market Share by Revenue
2.5.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Group ACYW135 Meningococcal Polysaccharide Vaccine Retrospective Market Scenario by Region
3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.3.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country
3.3.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country
3.4.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region
3.5.2 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.6.1 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country
3.6.2 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country
3.7.2 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Historic Market Analysis by Type
4.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type (2017-2022)
5 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Historic Market Analysis by Application
5.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Sanofi-Pasteur
6.1.1 Sanofi-Pasteur Corporation Information
6.1.2 Sanofi-Pasteur Description and Business Overview
6.1.3 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.1.5 Sanofi-Pasteur Recent Developments/Updates
6.2 Walvax Biotechnology
6.2.1 Walvax Biotechnology Corporation Information
6.2.2 Walvax Biotechnology Description and Business Overview
6.2.3 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.2.5 Walvax Biotechnology Recent Developments/Updates
6.3 Chengdu Kanghua Biological Products Co., Ltd
6.3.1 Chengdu Kanghua Biological Products Co., Ltd Corporation Information
6.3.2 Chengdu Kanghua Biological Products Co., Ltd Description and Business Overview
6.3.3 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.3.5 Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
6.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
6.4.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Corporation Information
6.4.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Description and Business Overview
6.4.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.4.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
6.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd
6.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Corporation Information
6.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Description and Business Overview
6.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments/Updates
6.6 Beijing Institute of Biological Products Co., Ltd
6.6.1 Beijing Institute of Biological Products Co., Ltd Corporation Information
6.6.2 Beijing Institute of Biological Products Co., Ltd Description and Business Overview
6.6.3 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.6.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
6.7 CanSino Biologics AG
6.6.1 CanSino Biologics AG Corporation Information
6.6.2 CanSino Biologics AG Description and Business Overview
6.6.3 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.7.5 CanSino Biologics AG Recent Developments/Updates
6.8 Yuxi Watson Biotechnology Co., Ltd
6.8.1 Yuxi Watson Biotechnology Co., Ltd Corporation Information
6.8.2 Yuxi Watson Biotechnology Co., Ltd Description and Business Overview
6.8.3 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.8.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
6.9 Hualan Biovaccine Co., Ltd
6.9.1 Hualan Biovaccine Co., Ltd Corporation Information
6.9.2 Hualan Biovaccine Co., Ltd Description and Business Overview
6.9.3 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.9.5 Hualan Biovaccine Co., Ltd Recent Developments/Updates
6.10 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
6.10.1 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Corporation Information
6.10.2 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Description and Business Overview
6.10.3 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.10.5 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Developments/Updates
7 Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Cost Analysis
7.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine
7.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Distributors List
8.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Customers
9 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Dynamics
9.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Trends
9.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Drivers
9.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Challenges
9.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Restraints
10 Global Market Forecast
10.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Group ACYW135 Meningococcal Polysaccharide Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Group ACYW135 Meningococcal Polysaccharide Vaccine by Type (2023-2028)
10.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Group ACYW135 Meningococcal Polysaccharide Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Group ACYW135 Meningococcal Polysaccharide Vaccine by Application (2023-2028)
10.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Group ACYW135 Meningococcal Polysaccharide Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Group ACYW135 Meningococcal Polysaccharide Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Group ACYW135 Meningococcal Polysaccharide Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Group ACYW135 Meningococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Group ACYW135 Meningococcal Polysaccharide Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
Table 16. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 20. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 24. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 40. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units) by Application (2017-2022)
Table 45. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 49. Sanofi-Pasteur Corporation Information
Table 50. Sanofi-Pasteur Description and Business Overview
Table 51. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 53. Sanofi-Pasteur Recent Developments/Updates
Table 54. Walvax Biotechnology Corporation Information
Table 55. Walvax Biotechnology Description and Business Overview
Table 56. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 58. Walvax Biotechnology Recent Developments/Updates
Table 59. Chengdu Kanghua Biological Products Co., Ltd Corporation Information
Table 60. Chengdu Kanghua Biological Products Co., Ltd Description and Business Overview
Table 61. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 63. Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
Table 64. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Corporation Information
Table 65. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Description and Business Overview
Table 66. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 68. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 69. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Corporation Information
Table 70. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Description and Business Overview
Table 71. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 73. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 74. Beijing Institute of Biological Products Co., Ltd Corporation Information
Table 75. Beijing Institute of Biological Products Co., Ltd Description and Business Overview
Table 76. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 78. Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 79. CanSino Biologics AG Corporation Information
Table 80. CanSino Biologics AG Description and Business Overview
Table 81. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 83. CanSino Biologics AG Recent Developments/Updates
Table 84. Yuxi Watson Biotechnology Co., Ltd Corporation Information
Table 85. Yuxi Watson Biotechnology Co., Ltd Description and Business Overview
Table 86. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 88. Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
Table 89. Hualan Biovaccine Co., Ltd Corporation Information
Table 90. Hualan Biovaccine Co., Ltd Description and Business Overview
Table 91. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 93. Hualan Biovaccine Co., Ltd Recent Developments/Updates
Table 94. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Corporation Information
Table 95. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Description and Business Overview
Table 96. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 98. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Group ACYW135 Meningococcal Polysaccharide Vaccine Distributors List
Table 102. Group ACYW135 Meningococcal Polysaccharide Vaccine Customers List
Table 103. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Trends
Table 104. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Drivers
Table 105. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Challenges
Table 106. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Restraints
Table 107. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 108. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 112. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 116. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 2. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Type in 2021 & 2028
Figure 3. Class I Vaccines Product Picture
Figure 4. Class II Vaccines Product Picture
Figure 5. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size (2017-2028) & (US$ Million)
Figure 10. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (2017-2028) & (K Units)
Figure 11. Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2021
Figure 12. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Group ACYW135 Meningococcal Polysaccharide Vaccine Players: Market Share by Revenue in 2021
Figure 14. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region in 2021
Figure 17. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
Figure 18. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region in 2021
Figure 19. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Colombia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Group ACYW135 Meningococcal Polysaccharide Vaccine by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 44. Manufacturing Process Analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 45. Group ACYW135 Meningococcal Polysaccharide Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
